TITLE

Oral Chemotherapy in the Treatment of Hormone-Refractory Prostate Cancer

AUTHOR(S)
Pienta, K.J.; Kamradt, J.M.; Smith, D.C.
PUB. DATE
December 1999
SOURCE
Drugs;Dec1999 Supplement 3, Vol. 58 Issue 6, p127
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Oral chemotherapy has become a major component of the treatment of advanced prostate cancer. The recognition that prostate cancer grows very slowly and must be treated continuously with active agents has led to the development of several therapeutic regimens. These regimens employ oral agents such as estramustine, cyclophosphamide, and etoposide, as they can be taken on a daily basis at home by the patients. These regimens have demonstrated activity in patients with hormone-refractory prostate cancer; declines in both prostate specific antigen and soft tissue lesions have been demonstrated.
ACCESSION #
9593654

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics